Back to ALGS

D. E. Shaw & Co., Inc. → ALGS

D. E. Shaw & Co., Inc. ALGS Position History

Aligos Therapeutics, Inc. • Healthcare

Quarters held
6
Latest value
$96K
Q3 2026
Peak value
$307K
First seen
Q2 2022

Dollar value over time

Show data table
PeriodPosition value
Q2 2022$187K
Q3 2022$35K
Q2 2026$254K
Q2 2026$130K
Q3 2026$307K
Q3 2026$96K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$96K17.0K——
Q3 2026$307K54.5K——
Q2 2026$130K22.5K——
Q2 2026$254K44.0K——
Q3 2022$35K31.6K——
Q2 2022$187K154.9K——

Other funds holding ALGS

Other D. E. Shaw & Co., Inc. positions

SPY

STATE STR SPDR S&P 500 ETF T

$7.6B
SPY

STATE STR SPDR S&P 500 ETF T

$6.8B
SPY

SPDR S&P 500 ETF TR

$2.6B
NVDA

NVIDIA CORPORATION

$2.3B
NVDA

NVIDIA CORPORATION

$2.3B
NVDA

NVIDIA CORPORATION

$2.3B
SPY

SPDR S&P 500 ETF TR

$2B
NVDA

NVIDIA CORPORATION

$2B